课题基金 / 基金详情

Detection of Epstein-Barr virus gene products, p53 protein and bcl-2 protein in nasopharyngeal carcinoma.

Detection of Epstein-Barr virus gene products, p53 protein and bcl-2 protein in nasopharyngeal carcinoma.
鼻咽癌中EB病毒基因产物、p53蛋白和bcl-2蛋白的检测
批准号:
06454485
负责人:
FURUKAWA Mitsuru
金额:
$3.33万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

FURUKAWA Mitsuru的其他基金

相似基金

相关文献

中文摘要
翻译
鼻咽癌(NPC)是一种上皮性肿瘤,其发病率具有显著的地理和人群差异,与eb病毒(EBV)一致相关。在肿瘤内,EBV DNA就重复序列而言是同质和克隆的,这表明肿瘤也是克隆的。在本研究中,我们采用聚合酶链式反应(PCR)检测EBV- dna和原位杂交检测EBV编码小rna (EBERs),以检测福尔马林固定石蜡包埋鼻咽癌标本中的EBV。3例角化鳞状细胞癌(SCC)、24例非角化癌(NKC)、13例未分化癌(UNPC)和2例腺癌(AC)均未检测到EBV-DNA。5例SCC中无EBERs, 32例NKC中30例,UNPC中16例,ac中无EBERs。在56例原发性鼻咽癌中,用BHLF寡核苷酸探针进行原位杂交,用LMP1、EBNA2、BZLF1蛋白、p53蛋白和bcl-2蛋白单克隆抗体进行免疫组化。17例(30%)检测到LMP1,而EBNA2未检测到。Bcl-2蛋白在50例(89%)中呈阳性,但其表达不依赖于LMP1的表达,LMP1在体外不诱导Bcl-2。18例(32%)细胞质中检测到BZLF1表达,而BHLF仅在6例(11%)中呈阳性。这一发现表明,尽管BZLF1的表达,但它破坏了病毒的潜伏期功能障碍。p53蛋白阳性31例(55%),BZLF1与p53蛋白表达有显著相关性(p<0.001)。提示BZLF1与p53相互失活的相互作用是鼻咽癌的致瘤因子之一
英文摘要
Nasopharyngeal carcinoma (NPC), an epithelial tumor which is characterized by marked geographic and population differences in incidence, is consistently associated with the Epstein-Barr virus (EBV). Within the tumor, the EBV DNA is homogeneous and clonal with regard to repeat sequences suggesting that the tumor is also clonal.In this work we examined to detect EBV in formalin-fixed paraffin-embedded NPC specimens by using both polymerase chain reaction (PCR) for EBV-DNA and in situ hybridization for EBV-encoded small RNAs (EBERs). EBV-DNA was detected in none of 3 keratinizing squamous cell carcinomas (SCC), 22 of 24 non-keratinizing carcinomas (NKC), all 13 undifferentiated carcinoma (UNPC) and none of 2 adenocarcinomas (AC). EBERs was detected in none of 5 SCC,30 of 32 NKC,16 of 17 UNPC and none of 2 AC.As an additional study in situ hybridization using BHLF oligonucleotide probes and immunohistochemistry using monoclonal antibodies against LMP1, EBNA2, BZLF1 protein, p53 protein and bcl-2 protein were performed in 56 primary NPC.LMP1 was detected in 17 cases (30%) whereas EBNA2 was not detectable. Bcl-2 protein was positive in 50 cases (89%), but its expression did not depend on expression of LMP1, which did not demonstrate induction of bcl-2 by LMP1 as seen in vitro. Cytoplasmic BZLF1 expression was detectable in 18 cases (32%) whereas BHLF was positive only in 6 cases (11%). This finding suggests BZLF1 which disrupts viral latency dysfunctions despite of its expression. p53 protein was positive in 31 cases (55%), and there was a distinct correlation between expression of BZLF1 and p53 protein (p<0.001). This finding suggests the interaction between BZLF1 and p53 which inactivates each other is one of tumorigenic factor in NPC
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
古川 仭 他: "上咽頭癌におけるEBV遺伝子発現と抗EBV抗体価の関係について" 臨床病理. 44. 832-833 (1996)
Takashi Furukawa 等人:“鼻咽癌中 EBV 基因表达与抗 EBV 抗体滴度之间的关系”《临床病理学》44. 832-833 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Nakagawa: "A clinical study of molecular biological diagnosis of metastases to cervical node from nasopharyngeal carcinoma" J.Juzen Med Soc.103(2). 265-275 (1994)
S.Nakakawa:“鼻咽癌颈淋巴结转移分子生物学诊断的临床研究”J.Juzen Med Soc.103(2)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
古川仭: "Epstein-Barrウイルス転写調節因子BZLF1タンパクに関する研究" 耳鼻咽喉科、頭頸部外科. 67(未定). (1995)
Takashi Furukawa:“Epstein-Barr 病毒转录调节因子 BZLF1 蛋白的研究”,耳鼻喉科,头颈外科 67(待定)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
室野重之 他: "上咽頭癌におけるEpstein-Barrウイルス遺伝子産物およびp53蛋白,bcl-2蛋白発現に関する研究" 金沢大学十全医学会雑誌. 105. 187-202 (1996)
Shigeyuki Murono 等:“鼻咽癌中 Epstein-Barr 病毒基因产物、p53 蛋白和 Bcl-2 蛋白表达的研究”金泽大学十善医学会杂志 105. 187-202 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Identification and cell line establishment of human osteoclast precursor cell
    • 批准号:
      22591690
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      FURUKAWA Mitsuru
    • 依托单位:
    Analysis of IL-27 receptor deficient mouse induced by inflammatory bone destruction model
    • 批准号:
      20791055
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.66万
    • 财政年份:
      2008
    • 负责人:
      FURUKAWA Mitsuru
    • 依托单位:
    Molecular biological analysis of Siah1 in EBV related tumor including nasopharyngeal cancer
    • 批准号:
      19390433
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2007
    • 负责人:
      FURUKAWA Mitsuru
    • 依托单位:
    The relationship between single nucleotide polymorphism of matrix metallopraeinase-1 and metastasis of nasopharyngeal carcinoma.
    • 批准号:
      16390487
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2004
    • 负责人:
      FURUKAWA Mitsuru
    • 依托单位:
    国内基金
    海外基金
    EB病毒核抗原1通过靶向PPP1CA稳定自身表达及其调控EBV潜伏感染的作用和机制研究
    • 批准号:
      2026JJ50144
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      卢建红
    • 依托单位:
    EBV-RBM4通过稳定HOXB13 mRNA促进鼻咽癌细胞上皮-间质转化及恶性进展
    EBV上调E3连接酶RNF114抑制鼻咽癌细胞Necroptosis机制研究
    • 批准号:
      2026JJ81963
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘文斌
    • 依托单位:
    EBV-miR-BART19-3p抑制GADD45B增强cyclinB1/CDK1结合促进EBV相关胃癌细胞增殖的机制研究
    • 批准号:
      2025JJ81046
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      阳静
    • 依托单位: